Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
NeuroBo Pharmaceuticals (NRBO)
NASDAQ:NRBO
NeuroBo Pharmaceuticals (NRBO) Stock Price & Analysis
309 Followers
NRBO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.89 - $6.75
Previous Close$3.4
Volume7.57K
Average Volume (3M)1.35M
Market Cap
$18.08M
Enterprise Value-$11.38M
Total Cash (Recent Filing)$28.70M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-1.4
Beta-0.45
Next Earnings
Aug 13, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.46
Shares Outstanding4,906,032
10 Day Avg. Volume26,403
30 Day Avg. Volume1,348,881
Standard Deviation0.25
R-Squared0.00280
Alpha-0.08
Financial Highlights & Ratios
Price to Book (P/B)0.80
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda1.39
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
NeuroBo Pharmaceuticals News
PremiumCompany Announcements
NeuroBo Pharmaceuticals Announces Key Leadership Appointment
PremiumCompany Announcements
NeuroBo Pharmaceuticals Signals Updates in Corporate Outlook
PremiumCompany Announcements
NeuroBo’s DA-1726 Obesity Therapy Gets FDA IND ApprovalRisk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
NRBO FAQ
What was NeuroBo Pharmaceuticals’s price range in the past 12 months?
NeuroBo Pharmaceuticals lowest stock price was $2.89 and its highest was $6.75 in the past 12 months.
What is NeuroBo Pharmaceuticals’s market cap?
Currently, no data Available
When is NeuroBo Pharmaceuticals’s upcoming earnings report date?
NeuroBo Pharmaceuticals’s upcoming earnings report date is Aug 13, 2024 which is in 111 days.
How were NeuroBo Pharmaceuticals’s earnings last quarter?
NeuroBo Pharmaceuticals released its earnings results on Mar 28, 2024. The company reported -$1.05 earnings per share for the quarter, missing the consensus estimate of -$0.785 by -$0.265.
Is NeuroBo Pharmaceuticals overvalued?
According to Wall Street analysts NeuroBo Pharmaceuticals’s price is currently Overvalued.
Does NeuroBo Pharmaceuticals pay dividends?
NeuroBo Pharmaceuticals does not currently pay dividends.
What is NeuroBo Pharmaceuticals’s EPS estimate?
NeuroBo Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NeuroBo Pharmaceuticals have?
NeuroBo Pharmaceuticals has 4,906,032 shares outstanding.
What happened to NeuroBo Pharmaceuticals’s price movement after its last earnings report?
NeuroBo Pharmaceuticals reported an EPS of -$1.05 in its last earnings report, missing expectations of -$0.785. Following the earnings report the stock price went down -5.76%.
Which hedge fund is a major shareholder of NeuroBo Pharmaceuticals?
Currently, no hedge funds are holding shares in NRBO
---
NeuroBo Pharmaceuticals Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
NRBO Sentiment 100%
Sector Average 70%
Sector Average 70%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▼ 5.6%
Last 30 Days ▼ 5.6%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-41.78%
12-Months-Change
Fundamentals
Return on Equity
-64.89%
Trailing 12-Months
Asset Growth
-32.07%
Trailing 12-Months
Company Description
NeuroBo Pharmaceuticals
NeuroBo Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat neurodegenerative disorders. The company was founded on October 30, 2014 and is headquartered in Boston, MA.
---
Technical Analysis
---